Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China · Delayed Price · Currency is CNY 4.990
-0.100 (-1.96%)
Jun 2, 2026, 3:04 PM CST
SHE:300318 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -95.15 | -91.92 | 9.25 | -24.93 | -78.44 | -322.18 |
Depreciation & Amortization | 98.08 | 98.08 | 103.68 | 112.92 | 109.37 | 107.66 |
Other Amortization | 15.74 | 15.74 | 11.95 | 10.48 | 10.02 | 8.93 |
Loss (Gain) From Sale of Assets | 0.37 | 0.37 | -0.12 | -1.11 | -31.97 | -0.14 |
Asset Writedown & Restructuring Costs | 63.87 | 63.87 | 2.56 | 3.34 | 17.55 | 361.11 |
Loss (Gain) From Sale of Investments | 9.18 | 9.18 | -1.15 | -1.5 | -0 | -4.62 |
Provision & Write-off of Bad Debts | 1.99 | 1.99 | 1.71 | 1.3 | 2.29 | 0.61 |
Other Operating Activities | -23.34 | -17.86 | 33.32 | 78.04 | -10.84 | -135.55 |
Change in Accounts Receivable | -52.78 | -52.78 | -11.89 | 1.7 | 45 | 60.97 |
Change in Inventory | -165.41 | -165.41 | -156.37 | 15.95 | -50.84 | -31.4 |
Change in Accounts Payable | 7.59 | 7.59 | -27.87 | -56.57 | 30.99 | -44.32 |
Operating Cash Flow | -143.87 | -135.17 | -38.69 | 137.02 | 40.72 | 0.89 |
Operating Cash Flow Growth | - | - | - | 236.49% | 4486.63% | -98.97% |
Capital Expenditures | -151.1 | -156.92 | -188.95 | -197.54 | -161.46 | -367.06 |
Sale of Property, Plant & Equipment | 65.16 | 30.3 | 0.31 | 21.78 | 21.69 | 0.28 |
Cash Acquisitions | -176.01 | - | - | - | - | - |
Investment in Securities | 180.89 | 1.22 | 2.05 | 6.49 | 0 | -12.17 |
Other Investing Activities | 0.21 | - | - | - | - | - |
Investing Cash Flow | -80.84 | -125.41 | -186.6 | -169.27 | -139.77 | -379.01 |
Short-Term Debt Issued | - | 1,268 | 685.25 | 902 | 830.2 | 868.1 |
Long-Term Debt Issued | - | 1,003 | 665.88 | 736.87 | 783.21 | 547.28 |
Total Debt Issued | 1,788 | 2,271 | 1,351 | 1,639 | 1,613 | 1,415 |
Short-Term Debt Repaid | - | -997.3 | -690.19 | -820.5 | -1,251 | -404.5 |
Long-Term Debt Repaid | - | -932.32 | -429.98 | -758.97 | -566.77 | -615.29 |
Total Debt Repaid | -1,975 | -1,930 | -1,120 | -1,579 | -1,817 | -1,020 |
Net Debt Issued (Repaid) | -186.42 | 341.59 | 230.97 | 59.4 | -204.07 | 395.59 |
Common Dividends Paid | -28.87 | -31.38 | -32.66 | -51.15 | -26.75 | -25.95 |
Other Financing Activities | 313.84 | -2 | - | - | 403.42 | - |
Financing Cash Flow | 98.55 | 308.21 | 198.31 | 8.25 | 172.6 | 369.64 |
Foreign Exchange Rate Adjustments | -0.44 | -0.24 | -0.87 | -0.01 | -0.21 | -0.24 |
Net Cash Flow | -126.6 | 47.39 | -27.85 | -24.01 | 73.34 | -8.72 |
Free Cash Flow | -294.97 | -292.09 | -227.64 | -60.53 | -120.74 | -366.17 |
Free Cash Flow Margin | -36.29% | -35.42% | -26.73% | -5.79% | -15.17% | -51.23% |
Free Cash Flow Per Share | -0.36 | -0.36 | -0.28 | -0.07 | -0.15 | -0.45 |
Cash Income Tax Paid | 77.11 | 77.37 | 79.65 | 97.21 | -19.2 | 43.26 |
Levered Free Cash Flow | 376.87 | 45.55 | -228.9 | -76.95 | -1,523 | 204.36 |
Unlevered Free Cash Flow | 394.39 | 66.44 | -210.8 | -59.69 | -1,497 | 232.53 |
Change in Working Capital | -214.61 | -214.61 | -199.89 | -41.52 | 22.75 | -14.95 |